Further research is needed, but this is a great start
Hoffman and his team expressed their optimism in gene therapy as a promising treatment option in humans. However, they noted that further research needs to be conducted in clinical trials in order to better understand the exact mechanics of how the process works, as well as its safety and effectiveness. “Our results are very promising. We have demonstrated that stable immune tolerance can be re-established and that active disease can be stopped and clinical symptoms reversed using our gene immunotherapy, especially during early onset of disease. Even though these studies were performed in a less complex mouse model, the data suggest this may be a potential therapy in humans with additional optimization” said Hoffman.